Shares of Organovo Holdings, Inc. (NASDAQ:ONVO) have been assigned an average recommendation of “Hold” from the eight research firms that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and four have given a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $3.60.

A number of research analysts have weighed in on ONVO shares. ValuEngine lowered shares of Organovo from a “sell” rating to a “strong sell” rating in a research report on Friday, September 1st. Jefferies Group LLC reissued a “buy” rating and set a $4.00 target price on shares of Organovo in a research report on Thursday, September 14th. Zacks Investment Research raised shares of Organovo from a “hold” rating to a “buy” rating and set a $2.25 target price for the company in a research report on Wednesday, October 11th. Raymond James Financial, Inc. lowered shares of Organovo from an “outperform” rating to a “market perform” rating and set a $5.00 target price for the company. in a research report on Friday, November 10th. Finally, Citigroup Inc. lowered shares of Organovo to a “market perform” rating in a research report on Friday, November 10th.

Large investors have recently bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of Organovo by 8.5% during the 1st quarter. Vanguard Group Inc. now owns 4,250,017 shares of the medical research company’s stock worth $13,515,000 after purchasing an additional 333,034 shares during the period. Ark Investment Management LLC increased its holdings in shares of Organovo by 134.5% during the 2nd quarter. Ark Investment Management LLC now owns 1,445,039 shares of the medical research company’s stock worth $3,800,000 after purchasing an additional 828,787 shares during the period. Metropolitan Life Insurance Co. NY increased its holdings in shares of Organovo by 15.0% during the 1st quarter. Metropolitan Life Insurance Co. NY now owns 68,487 shares of the medical research company’s stock worth $218,000 after purchasing an additional 8,958 shares during the period. Essex Investment Management Co. LLC increased its holdings in shares of Organovo by 27.3% during the 3rd quarter. Essex Investment Management Co. LLC now owns 458,774 shares of the medical research company’s stock worth $1,018,000 after purchasing an additional 98,417 shares during the period. Finally, Teachers Advisors LLC increased its holdings in shares of Organovo by 40.9% during the 2nd quarter. Teachers Advisors LLC now owns 235,489 shares of the medical research company’s stock worth $619,000 after purchasing an additional 68,412 shares during the period. Institutional investors own 26.84% of the company’s stock.

Shares of Organovo (NASDAQ ONVO) opened at $1.52 on Monday. Organovo has a 52 week low of $1.32 and a 52 week high of $4.08.

Organovo (NASDAQ:ONVO) last released its earnings results on Thursday, November 9th. The medical research company reported ($0.09) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.10) by $0.01. The firm had revenue of $1.36 million during the quarter, compared to analyst estimates of $1.38 million. Organovo had a negative net margin of 923.89% and a negative return on equity of 65.63%. The company’s quarterly revenue was down 1.4% on a year-over-year basis. research analysts forecast that Organovo will post -0.36 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This report was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/11/27/organovo-holdings-inc-onvo-given-average-recommendation-of-hold-by-brokerages.html.

Organovo Company Profile

Analyst Recommendations for Organovo (NASDAQ:ONVO)

Receive News & Ratings for Organovo Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.